DK315381A - Fremgangsmaade til fremstilling af substituerede pyrimidin-2-oner eller salte deraf - Google Patents

Fremgangsmaade til fremstilling af substituerede pyrimidin-2-oner eller salte deraf

Info

Publication number
DK315381A
DK315381A DK315381A DK315381A DK315381A DK 315381 A DK315381 A DK 315381A DK 315381 A DK315381 A DK 315381A DK 315381 A DK315381 A DK 315381A DK 315381 A DK315381 A DK 315381A
Authority
DK
Denmark
Prior art keywords
salts
group
compounds
susceptible
phase
Prior art date
Application number
DK315381A
Other languages
English (en)
Inventor
G H Phillipps
C Williamson
I P Steeples
B M D Bain
R A Borella
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of DK315381A publication Critical patent/DK315381A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK315381A 1980-07-15 1981-07-15 Fremgangsmaade til fremstilling af substituerede pyrimidin-2-oner eller salte deraf DK315381A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8023083 1980-07-15

Publications (1)

Publication Number Publication Date
DK315381A true DK315381A (da) 1982-01-16

Family

ID=10514776

Family Applications (1)

Application Number Title Priority Date Filing Date
DK315381A DK315381A (da) 1980-07-15 1981-07-15 Fremgangsmaade til fremstilling af substituerede pyrimidin-2-oner eller salte deraf

Country Status (12)

Country Link
US (1) US4650800A (da)
EP (1) EP0044705B1 (da)
JP (1) JPS5740483A (da)
AT (1) ATE10256T1 (da)
AU (1) AU7300281A (da)
CA (1) CA1159830A (da)
DE (1) DE3167186D1 (da)
DK (1) DK315381A (da)
ES (1) ES503985A0 (da)
NO (1) NO812432L (da)
NZ (1) NZ197715A (da)
ZA (1) ZA814843B (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8420610D0 (en) * 1984-08-14 1984-09-19 Glaxo Group Ltd Chemical compounds
JPH0679095B2 (ja) * 1986-04-03 1994-10-05 旭硝子株式会社 プラスチツククラツド光伝送フアイバ−

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1561290A (en) * 1975-10-16 1980-02-20 Nyegaard & Co As Pyrimid - 2 - ones
ES498337A0 (es) * 1980-01-07 1982-06-01 Nyegaard & Co As Un procedimiento para la preparacion de 5-halo-pirimidin-2- onas

Also Published As

Publication number Publication date
ES8300750A1 (es) 1982-11-01
NZ197715A (en) 1984-12-14
ES503985A0 (es) 1982-11-01
US4650800A (en) 1987-03-17
NO812432L (no) 1982-01-18
ATE10256T1 (de) 1984-11-15
ZA814843B (en) 1983-02-23
DE3167186D1 (en) 1984-12-20
AU7300281A (en) 1982-01-21
CA1159830A (en) 1984-01-03
EP0044705A1 (en) 1982-01-27
EP0044705B1 (en) 1984-11-14
JPS5740483A (en) 1982-03-06

Similar Documents

Publication Publication Date Title
DK315281A (da) Fremgangsmaade til fremstilling af pyrimidin-2-oner eller salte deraf
DK3281A (da) Fremgangsmaade til fremstilling af 2-halogenpyrimid-2-oner eller salte deraf
ATE3294T1 (de) 6-aminosubstituierte n-pyrrolyl-3-pyridazinamine, deren herstellung und sie enthaltende pharmazeutische antihypertensive zusammensetzungen.
DK315381A (da) Fremgangsmaade til fremstilling af substituerede pyrimidin-2-oner eller salte deraf
SE7709158L (sv) Nya substituerade 2-fenylaminoimidazolin-(2)-er, syraadditionssalter derav, lekemedel som innehaller dessa och forfarande for framstellning derav
PT76614A (de) Thiomethylpyridin-derivate verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DK146688C (da) Analogifremgangsmaade til fremstilling af substituerede 2-phenylamino-imidazoliner-(2)
NO159596C (no) Analogifremgangsm te for fremstilling av terapeutisk aktive indolderivater.
NO157214C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolcarboxylsyrederivater.
NO151465C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolderivater og syreaddisjonssalter derav
ES479110A1 (es) Procedimiento para preparar derivados de benzamidina.
NO830644L (no) Fremgangsmaate for fremstilling av fysiologisk aktive pyrimidin-2-oner.

Legal Events

Date Code Title Description
ATS Application withdrawn